Search This Blog

Wednesday, August 7, 2019

Ionis Pharmaceuticals EPS beats by $0.26, beats on revenue

Ionis Pharmaceuticals (NASDAQ:IONS): Q2 GAAP EPS of -$0.01 beats by $0.26.
Revenue of $164M (+39.0% Y/Y) beats by $18.69M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)